Exsilio Therapeutics Funding: $82M Raised, Series A (2024)
Exsilio Therapeutics is based in Boston, MA. It has raised $82M in total funding. Latest round: Series A.
Exsilio Therapeutics funding overview
Exsilio Therapeutics is based in Boston, MA. Exsilio Therapeutics has raised $82M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2024. The round record for Exsilio Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Novartis Venture Fund, Delos Capital, OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics and 4 others. 10 distinct backers are named across the disclosed rounds.
Exsilio Therapeutics at a glance
Total raised
$82M
Latest round
Series A
Latest round date
June 2024
Headquarters
Boston, MA
Notable investors
Novartis Venture Fund, Delos Capital, OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics, Innovation Endeavors, Invus
Frequently asked about Exsilio Therapeutics funding
How much has Exsilio Therapeutics raised?
Exsilio Therapeutics has raised $82M in total disclosed funding across the rounds on record.
Who has invested in Exsilio Therapeutics?
Novartis Venture Fund, Delos Capital, OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics are named among the investors backing Exsilio Therapeutics.
What was the latest Exsilio Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2024.
Where is Exsilio Therapeutics based?
Exsilio Therapeutics is based in Boston, MA.
When did Exsilio Therapeutics last raise?
The last disclosed Exsilio Therapeutics round closed in June 2024 at Series A.
We update the Exsilio Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.
